PlainRecalls
FDA Drug Moderate Class II Terminated

Temozolomide Capsules, 180 mg, packaged in a) 5-count bottles (NDC 0378-5264-98), b) 14-count bottles (NDC 0378-5264-14), Rx only, Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 USA.

Reported: February 1, 2017 Initiated: December 20, 2016 #D-0443-2017

Product Description

Temozolomide Capsules, 180 mg, packaged in a) 5-count bottles (NDC 0378-5264-98), b) 14-count bottles (NDC 0378-5264-14), Rx only, Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 USA.

Reason for Recall

Failed Tablet/Capsule Specifications: customer complaints of broken or crushed capsules, resulting in loose powder in the bottle.

Details

Recalling Firm
Mylan LLC.
Units Affected
a) 300 bottles (lot 2006915); b) 156 bottles (lot 2006914)
Distribution
Nationwide in the USA
Location
Caguas, PR

Frequently Asked Questions

What product was recalled?
Temozolomide Capsules, 180 mg, packaged in a) 5-count bottles (NDC 0378-5264-98), b) 14-count bottles (NDC 0378-5264-14), Rx only, Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 USA.. Recalled by Mylan LLC.. Units affected: a) 300 bottles (lot 2006915); b) 156 bottles (lot 2006914).
Why was this product recalled?
Failed Tablet/Capsule Specifications: customer complaints of broken or crushed capsules, resulting in loose powder in the bottle.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 1, 2017. Severity: Moderate. Recall number: D-0443-2017.